Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 53   

Articles published

ARNA 4.06 +0.02 (0.50%)
price chart
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) Fights for Share of Weight-loss Pill ...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA, ARNA message board) is expected to launch its patented Belviq treatment early next year, but there are some doubts that by that time Vivus, Inc. (NASDAQ:VVUS) will have made its Qsymia something of a ...
Arena: DEA Schedule IV Will Make Belviq The Obesity Blockbuster Drug
In addition, Arena comes with some enticing benefits for a pharmaceutical suitor - 10 year Swiss Tax Haven and R&D Write-offs.
Obesity Drugs Gain Attention on FDA Backing for Therapies
Third Rock Ventures is an early backer of Zafgen Inc., a biotechnology company in mid-stage trials of a therapy to treat obesity. The Food and Drug Administration cleared Belviq, from Arena Pharmaceuticals Inc. and Eisai Co., in June and Vivus Inc.'s ...
Analysts eye generic threat as Vivus rolls out Qsymia  FiercePharma
All Eyes On Vivus As Weight Loss Drug Hits Market  YCharts
UWM prof launches TCARE, a caregiver support company
Rhonda Montgomery, a University of Wisconsin-Milwaukee social work professor, has started a caregiver support company that seeks to provide better outcomes for family caregivers and their patients.
Arthritis drug kick-starts Rigel, partner
Rigel Pharmaceuticals Inc. is in strange territory. After spending nearly $700 million over 16 years developing drugs, the low-key South San Francisco biotech company has an experimental rheumatoid arthritis drug swiftly heading toward a date with the FDA.
Ten Pharmaceutical Companies Unite to Accelerate Development of New Medicines
Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech a member of the Roche Group, and Sanofi launched TransCelerate BioPharma Inc. ("TransCelerate"), the largest ...
Dr. Jean-Paul Castaigne, CEO of Angiochem
Yet the most exciting developments for Angiochem this year have been in the rare-diseases arena. The company raised its profile and brought publicity to its preclinical efforts in transporting enzyme drugs for orphan disorders into the brain in ...
Are pet drugs like contact lenses?
The antitrust litigation did more to open the market than the Fairness to Contact Lens Consumers Act, which followed two years later, said Menderes “Mendo” Akdag, a former president and CEO of Lens Express Inc., a seller of replacement contact lenses.
Bill Clinton, Medicaid and the Politics of Poverty
(�146 million) sale of the company in 2005, while Mr Romney remained in office. ..... In fact, Romneycare provided for taxpayer funded abortifacients (Pharmaceuticals that cause spontaneous abortion) How many evangelicals and catholics know this? He ...
The Rev. Sun Myung Moon to be laid to rest in South Korea
Prayers, singing, floral tributes and eulogies are expected as the remains of Moon arrive at the arena. After a two-hour ceremony, he will be laid to rest on Mount Cheonseong in the northern South Korean province of Gyeonggi -- known as the "holy land ...